Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Joseph Deily

Physician Assistant, Surgical Fort Myers, FL Physician Assistant

NPI 1952337636 CMS profile 11082371

9981 S Healthpark Dr, Ste 156, Fort Myers, FL 33908

Open in the dashboard

General payments

$52,425

145 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Deily of Fort Myers, FL is reported in the CMS Open Payments database as having received $52,425 across 145 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $734 15
2024 General $7,845 19
2023 General $19,807 35
2022 General $15,491 46
2021 General $8,548 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Deily
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Joseph Deily were reported at $734. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Joseph Deily Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $8,548 $111 $36–$285 $132
2022 $15,491 $126 $44–$350 $149
2023 $19,807 $137 $47–$355 $160
2024 $7,845 $146 $49–$384 $164
2025 $734 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Atricure, Inc. $42,381 93 payments
  2. Haemonetics Corporation $7,011 5 payments
  3. Medtronic, Inc. $1,372 32 payments
  4. Maquet Cardiovascular U.S. Sales, L.L.C. $496 3 payments
  5. Medical Device Business Services, Inc. $220 2 payments
  6. Abiomed $204 2 payments
  7. Stryker Corporation $170 2 payments
  8. Solventum Corporation $136 1 payment
  9. Idorsia Pharmaceuticals US Inc $125 1 payment
  10. Edwards Lifesciences Corporation $120 1 payment
  11. Other $190 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $37,100 33 payments
  2. Travel and Lodging $10,962 41 payments
  3. Food and Beverage $4,363 71 payments
Products named General payments · program years 2021–2025
  1. SYNERGY ABLATION SYSTEM $40,961 86 payments
  2. ATRICLIP LAA EXCLUSION SYSTEM $11,179 25 payments
  3. AtriCure cryoICE cryoSPHERE Cryoablation System $7,788 23 payments
  4. TEG6s HEMOSTASIS SYSTEM $6,991 4 payments
  5. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $6,960 18 payments
  6. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,094 4 payments
  7. COREVALVE EVOLUT R $1,058 28 payments
  8. Vasoview Hemopro 2 $469 2 payments
  9. Impella $204 2 payments
  10. STRYKER VARISPEED $170 2 payments
  11. Other $1,224 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

33

Median for Physician Assistant: 241

Drug cost

$132

Median for Physician Assistant: $4,110

Branded share of claims

33.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Potassium Chloride Generic 11 $86
Clopidogrel Clopidogrel Bisulfate Brand 11 $28
Metoprolol Tartrate Generic 11 $18

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$14,115

Medicare's payments for the services billed

Medicare patients

65

Average age 75

Services billed

141

18 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 60%
Arthritis 55%
Heart failure 54%
Diabetes 48%
COPD 42%
Cancer 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

145 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record